Investing.com -- LENZ Therapeutics (NASDAQ:LENZ) stock tumbled 25% on heavy volume Friday in New York after a case of retinal tear associated with its VIZZ eye drop appeared in the FDA’s adverse event ...
LENZ Therapeutics (LENZ) is aware of a recent adverse event report submitted to the U.S. Food and Drug Administration’s Adverse Event Reporting System database describing a retinal tear in a patient ...
The Pro Display XDR is six years old today, making it one of the oldest Apple products still on sale. Released on December 10 ...
Precision measurement technology to assure the quality of products on assembly lines across the U.S. -- Fostering an excellence in surgical care from the first precision clinical microscopes and ...